ARGOS THERAPEUTICS INC Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015	FY2014 12 months to Dec 31, 2014
Net loss
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Share-based compensation expense
Common stock issued as payment for services
Issuance of Common Stock as Payment for Research and Development Services
Total common stock issued as payment for services
Amortization of debt issuance costs
Amortization of debt discount
Interest accrued on long-term debt
Impairment loss on property and equipment
Gain on early extinguishment of debt
Decrease in fair value of warrant liability
Gain on disposal of impaired property
Other

Changes in operating assets and liabilities:
Prepaid expenses and other receivables
Other assets
Accounts payable
Accrued expenses
Manufacturing research and development obligation
Deferred liabilities
Net cash used in operating activities

Cash flows from investing activities
Purchase of property and equipment
Lease Agreement
Total purchase of property and equipment
Proceeds from sale of property and equipment
Purchases of short-term investments
Payment to restricted cash account securing letter of credit
(Payment to) receipt from restricted cash account securing letter of credit
Proceeds from maturity of short-term investments
Net cash provided by (used in) investing activities

Cash flows from financing activities
Proceeds from sale of common stock and warrants
Stock issuance costs
Proceeds from issuance of notes payable with detachable common stock warrants
Debt issuance costs
Proceeds from issuance of convertible note payable to related party
Payment on lease obligations
Lease Agreement
Power Generation Agreements
Total payment on lease obligations
Payments on notes payable
Proceeds from exercise of common stock warrants
Proceeds from exercise of employee stock purchase plan rights
Proceeds from exercise of common stock options
Net cash provided by (used in) financing activities
Effect of exchange rates changes on cash
Net (decrease) increase in cash and cash equivalents

Cash and cash equivalents
Beginning of period
End of period
Supplemental disclosure of cash flow information
Cash paid for interest
Supplemental disclosure of noncash investing and financing activities
Issuance of common stock for research and development and other services
Conversion of preferred stock into common stock
Interest accrued on long-term debt
Preferred stock accretion
Issuance of warrants in exchange for early extinguishment of debt
Issuance of convertible notes in exchange for early extinguishment of debt
Issuance of common stock in exchange for early extinguishment of debt
Interest capitalized on construction-in-progress
Purchases of property and equipment included in accounts payable and accrued expenses
Lease obligations incurred
Lease Agreement
Power Generation Agreements
Total lease obligations incurred
Stock issuance costs included in accounts payable and accrued expenses

Comments